2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease
Endocrinology and metabolism clinics of North America · 2022 Jun
Abstract
The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that include patient preference, age, comorbidity, pregnancy, tobacco smoking, and social determinants of health must all be weaved into a cohesive management plan. A multidisciplinary team is required to manage all aspects of Graves disease, particularly thyroid eye disease, for which new therapeutic options are now available.
Neurotransmitters
None linked yet.
Related
Community votes: 0
Ratings (0): Breadth — · Depth — · Enjoyment — · Usefulness —
Community
Log in to rate and share your notes.
No contributions yet.